ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 808

Assessing the Possible Link between Varicella Zoster Virus and Giant Cell Arteritis Using Clinical Assessment, Serology and Biopsy Antigen Detection – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Cohort

Anthony Sammel1, Katherine Nguyen2, Susan Smith3, Christopher Little3, Janice Brewer2 and Rodger Laurent2, 1Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, 2Royal North Shore Hospital, St Leonards, Sydney, Australia, 3Raymond Purves Bone and Joint Research Laboratories, Kolling Institute, Sydney, Australia

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: giant cell arteritis, Infection, serologic tests, vasculitis and viruses

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Vasculitis Poster I: Large Vessel Vasculitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent studies have suggested that giant cell arteritis (GCA) may be triggered by reactivation of varicella zoster virus (VZV) based on high rates of VZV antigen detected in temporal artery specimens. We attempted to replicate these findings and further validate the possible link between VZV and GCA by assessing clinical and serological markers of acute infection.

Methods: 24 patients suspected of having GCA were recruited prior to temporal artery biopsy (TAB) between July 2016 and April 2017. Patients were clinically evaluated for active and past VZV infection and had serum tested for VZV IgM and IgG. All were treated with high dose corticosteroids for at least one week while awaiting TAB and were followed clinically for at least one month. Formalin fixed biopsies were cut into a minimum of four sections and were stained using a mouse derived antibody against VZV antigen and reported by two experienced, blinded immunohistochemistry researchers.

Results: Mean age was 68 and 17 (71%) were female. 23 (96%) reported headache, 15 (63%) scalp tenderness and nine (38%) visual disturbance. Inflammatory changes were seen on seven (29%) biopsies; four had mural inflammation and three had limited periadventitial small vessel vasculitis (SVV). 16 (67%) met ACR criteria for GCA and 11 (46%) were assessed by the treating clinician as having definite or probable (>= 50% chance) GCA at two-week follow-up. No patients had clinical features of herpes zoster (shingles) at the time of enrolment. Six (25%) reported a history of zoster, 22 (92%) chickenpox and none had received the adult zoster vaccine. A single patient developed zoster ophthalmicus one week after commencing corticosteroids with subsequent ipsilateral biopsy showing SVV. All 24 biopsies stained negative for VZV antigen by immunohistochemistry. Of the 23 who had VZV serology, all were IgM negative. 21/23 (91%) were VZV IgG positive consistent with past exposure.

Conclusion: VZV antigen was not detected in biopsy specimens. IgM serology was negative in all 23 tested patients. Only one patient developed herpes zoster on follow-up. These interim results do not support a link between VZV and GCA.


Disclosure: A. Sammel, Arthritis Australia, 2; K. Nguyen, None; S. Smith, None; C. Little, None; J. Brewer, None; R. Laurent, None.

To cite this abstract in AMA style:

Sammel A, Nguyen K, Smith S, Little C, Brewer J, Laurent R. Assessing the Possible Link between Varicella Zoster Virus and Giant Cell Arteritis Using Clinical Assessment, Serology and Biopsy Antigen Detection – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/assessing-the-possible-link-between-varicella-zoster-virus-and-giant-cell-arteritis-using-clinical-assessment-serology-and-biopsy-antigen-detection-interim-results-from-the-giant-cell-arter/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-possible-link-between-varicella-zoster-virus-and-giant-cell-arteritis-using-clinical-assessment-serology-and-biopsy-antigen-detection-interim-results-from-the-giant-cell-arter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology